Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer

Eur J Cancer. 2014 Mar;50(5):1042-3. doi: 10.1016/j.ejca.2013.12.016. Epub 2014 Jan 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Kommentar

MeSH terms

  • Androstenols / therapeutic use*
  • Humans
  • Male
  • Phenylthiohydantoin / analogs & derivatives*
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Taxoids / therapeutic use*

Substances

  • Androstenols
  • Taxoids
  • Phenylthiohydantoin